2014, Number 4
<< Back Next >>
Correo Científico Médico 2014; 18 (4)
Presentation of a patient with gastrointestinal stromal tumor of gastric localization
Haliberto AB
Language: Spanish
References: 13
Page: 785-792
PDF size: 276.27 Kb.
ABSTRACT
A 35-year-old female patient without previous medical history, evaluated by surgical department in Honduras La Ceiba in May 2010 was presented in this paper. The patient referred occasionally abdominal pain located in epigastrium, mesogastrium since seven months ago, associated to digestive disorders and vomiting referred one episode of melena three months before. On physical examination a large 10 cm abdominal tumor was found, easy to move, painless on palpation without any signs of peritoneal reaction, abdominal ultrasound, blood test were performed, no other diagnostic studies could not be achieved because the condition of the country. Exploratory laparotomy was done and a large tumor that occupied more than a third part of the greater gastric curvature of the antrum and body of the stomach without palpable lymphadenopathy. Distal subtotal gastrectomy with Billroth II gastrojejunostomy antecolic, Polya technique was performed. The histopathology report confirmed the diagnosis of GIST. The patient was discharged with satisfactory evolution.
REFERENCES
Pardo Martínez C, Mayol Martínez J, Hernández Pérez C, Álvarez Fernández J. Gastric stromal tumors: clinical presentation and surgical options. Rev Esp Enferm Dig. 2004 [citado 1 abr 2014]; 96(8): 578-583. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid
Mazur MT, Clark HB. Gastric stromal tumors: reappraisal of histogenesis. Am J Surg Pathol. 1983[citado 1 abr 2014]; 7:507-519. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=Gastric+stromal+tumors%3A+reappraisal+of+histogenesis
Bernet L, Bustamante M, Zúñiga A, Cano R. Characterization of GIST/GIPACT tumors by immunohistochemistry and exon 11 analysis of c-kit gene by PCR. Rev Enferm Dig Esp. 2003[citado 14 abr 2014]; 95(10): 688-691. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/14588063
Goettsch WG, Bos SD, Breekveldt- Postma N. Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study. Eur J Cancer. 2005[citado 14 abr 2014]; 41(18):2868-72. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/16293410
Agaimy A, Wünsch PH, Hofstaedter F. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations.Am J Surg Pathol. 2007[citado 14 abr 2014]; 31:113. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?term=Minute+gastric+sclerosing+stromal+tumors+%28GIST+tumorlets%29+are+common+in+adults+and+frequently+show+c-KIT+mutations
Tzen CY, Wang JH, Huang YJ. Incidence of gastrointestinal stromal tumor: a retrospective study based on immunohistochemical and mutational analyses. Dig Dis Sci. 2007[citado 14 abr 2014]; 52(3):792-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/17253141
Agaimy A, Märkl B, Arnholdt H. Sporadic segmental Interstitial cell of cajal hyperplasia (microscopic GIST) with unusual diffuse longitudinal growth replacing the muscularis propria: differential diagnosis to hereditary GIST syndromes. Int J Clin Exp Pathol. 2010[citado 14 abr 2014]; 3(5):549-56. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20606738
Yan H, Marchettini P, Acherman YI, Gething SA, Brun E, Sugarba PH. Prognostic assessment of gastrointestinal stromal tumor. Am J Clin Oncol.2003 [citado 14 abr 2014]; 26(3): 221-228 Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/12796588
Sepe PS, Brugge WR. A guide for the diagnosis and management of gastrointestinal stromal cell tumors. Nat Rev Gastroenterol Hepatol. 2009[citado 14 abr 2014]; 6(6):363-71. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19365407
Kingham TP, DeMatteo RP. Multidisciplinary treatment of gastrointestinal stromal tumors. Surg Clin North Am. 2009[citado 14 abr 2014]; 89:217. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19186237
Gervaz P, Huber O, Morel P. Surgical management of gastrointestinal stromal tumours. J Surg Br.2009[citado 14 abr 2014]; 96:567. Disponible en: http://www.ncbi.nlm.nih.gov/pub
Gronchi A, Raut CP. The combination of surgery and imatinib in GIST: a reality for localized tumors at high risk, an open issue for metastatic ones. Ann Surg Oncol. 2012[citado 14 abr 2014]; 19:1051. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/?te
Fernández A, Aparicio J. Imatinib and gastrointestinal stromal tumor (gist): a selective targeted therapy. Rev Esp Enferm Dig 2003[citado 14 abr 2014]; 96(10): 723-729. Disponible en: http://dx.doi.org/10.4321/S1130-01082004001000007